BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 26318102)

  • 1. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
    Morgenweck J; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():600-9. PubMed ID: 26318102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys.
    Huskinson SL; Platt DM; Brasfield M; Follett ME; Prisinzano TE; Blough BE; Freeman KB
    Psychopharmacology (Berl); 2020 Jul; 237(7):2075-2087. PubMed ID: 32372348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
    Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.
    Ko MC; Lee H; Song MS; Sobczyk-Kojiro K; Mosberg HI; Kishioka S; Woods JH; Naughton NN
    J Pharmacol Exp Ther; 2003 Apr; 305(1):173-9. PubMed ID: 12649366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.
    Bruchas MR; Macey TA; Lowe JD; Chavkin C
    J Biol Chem; 2006 Jun; 281(26):18081-9. PubMed ID: 16648139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.
    Liu JJ; Chiu YT; DiMattio KM; Chen C; Huang P; Gentile TA; Muschamp JW; Cowan A; Mann M; Liu-Chen LY
    Neuropsychopharmacology; 2019 Apr; 44(5):939-949. PubMed ID: 30082888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation.
    Li JG; Luo LY; Krupnick JG; Benovic JL; Liu-Chen LY
    J Biol Chem; 1999 Apr; 274(17):12087-94. PubMed ID: 10207034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation.
    Li JG; Benovic JL; Liu-Chen LY
    Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism.
    Al-Hasani R; McCall JG; Foshage AM; Bruchas MR
    Neuropsychopharmacology; 2013 Nov; 38(12):2484-97. PubMed ID: 23787819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
    Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
    J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effects.
    Huang P; Chen C; Cao D; Huang M; Liu-Chen LY
    Neuropharmacology; 2022 Jan; 202():108860. PubMed ID: 34736959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship studies of functionally selective kappa opioid receptor agonists that modulate ERK 1/2 phosphorylation while preserving G protein over βarrestin2 signaling bias.
    Lovell KM; Frankowski KJ; Stahl EL; Slauson SR; Yoo E; Prisinzano TE; Aubé J; Bohn LM
    ACS Chem Neurosci; 2015 Aug; 6(8):1411-9. PubMed ID: 25891774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice.
    Kamei J; Nagase H
    Eur J Pharmacol; 2001 Apr; 418(1-2):141-5. PubMed ID: 11334876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase.
    Xu M; Bruchas MR; Ippolito DL; Gendron L; Chavkin C
    J Neurosci; 2007 Mar; 27(10):2570-81. PubMed ID: 17344394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient activation of the CA3 Kappa opioid system in the dorsal hippocampus modulates complex memory processing in mice.
    Daumas S; Betourne A; Halley H; Wolfer DP; Lipp HP; Lassalle JM; Francés B
    Neurobiol Learn Mem; 2007 Jul; 88(1):94-103. PubMed ID: 17374494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance.
    McLaughlin JP; Myers LC; Zarek PE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Chavkin C
    J Biol Chem; 2004 Jan; 279(3):1810-8. PubMed ID: 14597630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Intrathecal κ-Opioid Receptor Agonist on Morphine-Induced Itch and Antinociception in Mice.
    Sakakihara M; Imamachi N; Saito Y
    Reg Anesth Pain Med; 2016; 41(1):69-74. PubMed ID: 26587674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
    Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of cocaine-related behaviors by low doses of the potent KOR agonist nalfurafine in male C57BL6 mice.
    Dunn A; Windisch K; Ben-Ezra A; Pikus P; Morochnik M; Erazo J; Reed B; Kreek MJ
    Psychopharmacology (Berl); 2020 Aug; 237(8):2405-2418. PubMed ID: 32435819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.